Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Apoptosis : an International Journal on Programmed Cell Death|April 2, 2015
Apoptin interacts with and regulates the activity of protein kinase C beta in cancer cellsJessica Bullenkamp, Joop Gäken, Frederic Festy, et al.
Cell Death & Disease|July 17, 2019
Clinical update on head and neck cancer: molecular biology and ongoing challengesElham Alsahafi, Katheryn Begg, Ivano Amelio, et al.
Oncology Reports|April 12, 2024
Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma (Review)Voraporn Yongprayoon, Napasporn Wattanakul, Winnada Khomate, et al.
Cancer Research|August 20, 2010
Crucial roles for protein kinase C isoforms in tumor-specific killing by apoptinJie Jiang, Daryl Cole, Nigel Westwood, et al.
Cell Cycle (Georgetown, Tex.)|February 8, 2008
Specific isoforms of p73 control the induction of cell death induced by the viral proteins, E1A or apoptinPoramaporn Klanrit, Marcella B Flinterman, Edward W Odell, et al.
Materials Science & Engineering. C, Materials for Biological Applications|March 25, 2020
Some new nanostructure zinc complex: Synthesis, spectral analyses, crystal structure, Hirshfeld surface analyses, antimicrobial/anticancer, thermal behavior and usage as precursor for ZnO nanostructureMahvash Tavassoli, Morteza Montazerozohori, Reza Naghiha, et al.
Journal of Virology|August 12, 2016
Activation of the Chicken Anemia Virus Apoptin Protein by Chk1/2 Phosphorylation Is Required for Apoptotic Activity and Efficient Viral ReplicationThomas J Kucharski, Timothy F Ng, David M Sharon, et al.
Journal of Neurochemistry|November 2, 2006
TAp73 isoforms antagonize Notch signalling in SH-SY5Y neuroblastomas and in primary neuronesClaudie Hooper, Mahvash Tavassoli, J Paul Chapple, et al.
Cancer Letters|November 2, 2020
EGFR overexpression increases radiotherapy response in HPV-positive head and neck cancer through inhibition of DNA damage repair and HPV E6 downregulationElham Nafea Alsahafi, Selvam Thavaraj, Nazanin Sarvestani, et al.
Drug Development Research|February 26, 2025
Evaluation of Pyrrolone-Fused Benzosuberene MK2 Inhibitors as Promising Therapeutic Agents for HNSCC: In Vitro Efficacy, In-Vivo Safety, and Pharmacokinetic ProfilingPrince Anand, Jyoti Chhimwal, Sumit Dhiman, et al.
Pageof 5